Cited by 68Endometriosis Research and TreatmentReproductive Biology and FertilityOvarian function and disorders

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Endometriosis Triggers Excessive Activation of Primordial Follicles via PI3K-PTEN-Akt-Foxo3 Pathway

Takeuchi, Arisa, Koga, Kaori, Satake, Erina, Makabe, Tomoko, Taguchi, Ayumi, Miyashita, Mariko, Takamura, Masashi, Harada, Miyuki, Hirata, Tetsuya, Hirota, Yasushi, Yoshino, Osamu, Wada-Hiraike, Osamu, Fujii, Tomoyuki, Osuga, Yutaka·2019·The Journal of Clinical Endocrinology & Metabolism

Abstract

Context The ovarian reserve is reduced in patients with endometriosis. We hypothesize that the phosphatidylinositol 3-kinase (PI3K)-phosphatase and tensin homolog deleted on chromosome 10 (PTEN) Akt-Forkhead box O (Foxo3) pathway is involved in reducing the ovarian reserve. Objective To elucidate the signaling mechanism by which endometriosis decreases ovarian reserve. Design Studies were conducted by using a mouse model for endometriosis and human ovaries. The endometriosis mouse model was established and ammonium trichloro (dioxoethylene-o,o') tellurate (AS101), an inhibitor of PI3K-PTEN-Akt pathway, was administered to experimental mice. Human ovaries were collected during surgery from patients with endometrioma or from patients with no ovarian pathology (control ovaries). The number of follicles and expression of Foxo3, PTEN, phosphorylated mammalian target of rapamycin and phosphorylated Akt by oocytes in primordial follicles in mouse and human ovaries were detected by immunohistochemical staining and evaluated. Results In the endometriosis mouse model, the proportion of primordial follicles was diminished, and the proportion of primary, secondary, antral, and growing follicles was increased in comparison with controls. In both mouse and human ovaries, the PI3K-PTEN-Akt-Foxo3 pathway was activated in samples from endometriosis. Administration of AS101 restored the proportion of primordial follicles in endometriotic mice ovaries to control levels. Conclusions The current…

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2019-00281

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In ovaries affected by endometriosis, a higher proportion of primordial follicles are recruited into the growing pool and a greater number of maturing follicles degenerate, resulting in quicker depletion of ovarian reserve.

    “In ovaries affected by endometriosis, a higher proportion of primordial follicles are recruited into the growing pool and a greater number of maturing follicles degenerate, resulting in quicker depletion of ovarian reserve (Kitajima et al., 2014; Takeuchi et al., 2019).”

    From Endometriosis and polycystic ovary syndrome are diametric disorders (2021) · cites this paper as Takeuchi et al., 2019

  • Endometriosis is associated with lower ovarian reserve, increased primordial follicle recruitment, fewer antral follicles, and a steeper rate of decline in AMH.

    “Endometriosis, by contrast, is associated with lower ovarian reserve (Seyhan et al., 2015; Shah, 2013), increased primordial follicle recruitment (Takeuchi et al., 2019), fewer antral follicles (Muzii et al., 2018), and a steeper rate of decline in AMH (Kasapoglu et al., 2018).”

    From Endometriosis and polycystic ovary syndrome are diametric disorders (2021) · cites this paper as Takeuchi et al., 2019

  • Lower testosterone in women with endometriosis contributes to a faster pace of follicular recruitment and death.

    “Lower testosterone in women with endometriosis shows evidence of contributing to a faster pace of follicular recruitment and death, across several studies.”

    From Endometriosis and polycystic ovary syndrome are diametric disorders (2021) · cites this paper as Takeuchi et al., 2019

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 21

  1. Zondervan, 2018, Endometriosis, Nat Rev Dis Primers, 4, 9, 10.1038/s41572-018-0008-5 · DOI · Paper page
  2. Muzii, 2018, Antimüllerian hormone is reduced in the presence of ovarian endometriomas: a systematic review and meta-analysis, Fertil Steril, 110, 932, 10.1016/j.fertnstert.2018.06.025 · DOI · Paper page
  3. Kasapoglu, 2018, Endometrioma-related reduction in ovarian reserve (ERROR): a prospective longitudinal study, Fertil Steril, 110, 122, 10.1016/j.fertnstert.2018.03.015 · DOI · Paper page
  4. Ashrafi, 2019, The impact of the localisation of endometriosis lesions on ovarian reserve and assisted reproduction techniques outcomes, J Obstet Gynaecol, 39, 91-797, 10.1080/01443615.2018.1465898 · DOI
  5. Dolmans, 2007, Short-term transplantation of isolated human ovarian follicles and cortical tissue into nude mice, Reproduction, 134, 253, 10.1530/REP-07-0131 · DOI
  6. Kitajima, 2014, Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas, Fertil Steril, 101, 1031, 10.1016/j.fertnstert.2013.12.049 · DOI · Paper page
  7. Castrillon, 2003, Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a, Science, 301, 215, 10.1126/science.1086336 · DOI
  8. Liu, 2007, Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a, Development, 134, 199, 10.1242/dev.02667 · DOI
  9. Pelosi, 2013, Constitutively active Foxo3 in oocytes preserves ovarian reserve in mice, Nat Commun, 4, 1843, 10.1038/ncomms2861 · DOI
  10. Adhikari, 2010, mTOR signaling in the control of activation of primordial follicles, Cell Cycle, 9, 1673, 10.4161/cc.9.9.11626 · DOI
  11. Jagarlamudi, 2012, Oogenesis: transcriptional regulators and mouse models, Mol Cell Endocrinol, 356, 31, 10.1016/j.mce.2011.07.049 · DOI
  12. Takamura, 2016, Neutrophil depletion reduces endometriotic lesion formation in mice, Am J Reprod Immunol, 76, 193, 10.1111/aji.12540 · DOI · Paper page
  13. Kalich-Philosoph, 2013, Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility, Sci Transl Med, 5, 185ra62, 10.1126/scitranslmed.3005402 · DOI
  14. Myers, 2004, Methods for quantifying follicular numbers within the mouse ovary, Reproduction, 127, 569, 10.1530/rep.1.00095 · DOI
  15. Chang, 2015, Cisplatin Induces Overactivation of the Dormant Primordial Follicle through PTEN/AKT/FOXO3a Pathway which Leads to Loss of Ovarian Reserve in Mice, PLoS One, 10, e0144245, 10.1371/journal.pone.0144245 · DOI
  16. Sonigo, 2019, AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice, FASEB J, 33, 1278, 10.1096/fj.201801089R · DOI
  17. McKinnon, 2016, Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics, Hum Reprod Update, 22, 382, 10.1093/humupd/dmv060 · DOI
  18. Leconte, 2011, The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice, Am J Pathol, 179, 880, 10.1016/j.ajpath.2011.04.020 · DOI
  19. Matsuzaki, 2018, In vitro and in vivo effects of MK2206 and chloroquine combination therapy on endometriosis: autophagy may be required for regrowth of endometriosis, Br J Pharmacol, 175, 1637, 10.1111/bph.14170 · DOI
  20. Barra, 2018, Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis, Br J Pharmacol, 175, 3626, 10.1111/bph.14391 · DOI
  21. Esposito, Safety, tolerability, and management of toxic effects of phosphatidylinositol 3-kinase inhibitor treatment in patients with cancer: a review [published online ahead of print 28 March 2019], JAMA Oncol

Cited by

Sorted by citations

Metadata

Authors
Takeuchi, A., Koga, K., Satake, E., Makabe, T., Taguchi, A., Miyashita, M., Takamura, M., Harada, M., Hirata, T., Hirota, Y., Yoshino, O., Wada-Hiraike, O., Fujii, T., & Osuga, Y.
Affiliations
  • The University of Tokyo (JP)
  • Obstetrics and Gynecology, University of Tokyo, Hongo Bunkyo Tokyo, Japan
  • Kitasato University (JP)
Corresponding author
Koga, Kaori
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2019-06-20
Volume
104
Issue
11
Pages
5547-5554
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2951322526
Cited by
68
References
1
Citations by year
2026: 7 · 2025: 14 · 2024: 14 · 2023: 9 · 2022: 9 · 2021: 9 · 2020: 5 · 2019: 1
FWCI
5.97
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Japan Agency for Medical Research and Development (197100000040)
  • Japan Society for the Promotion of Science (187100000421)
  • Yamaguchi Endocrine Research Foundation (NA)
  • Shiseido Group (NA)
  • Society for Women's Health Science Research (NA)
  • Kanzawa Medical Research Foundation (NA)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Keywords
endometriosis, ovarian reserve, primordial follicles, FOXO3, AS101, PI3K inhibitors, endometrioma, folliculogenesis, mTOR, Akt phosphorylation
MeSH terms
Forkhead Box Protein O3, Animals, Disease Models, Animal, Endometriosis, Female, Ovarian Follicle, Humans, Ovary, Phosphorylation, Signal Transduction, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review